Company / EPS (Diluted)
SRx Health Solutions, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.95
FY2025
5-year range
-$58.93 / $0.14
FY2021-FY2025
Trend
+94.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 9 years, ranging from $-58.93 in FY2023 to $0.14 in FY2022.
Based on SEC 10-K filings.
-1.95 in FY2025.
Improved from $-58.93 to $-1.95 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 94.0% year-over-year.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.95 | +94.0% |
| FY2024 | -$32.29 | +45.2% |
| FY2023 | -$58.93 | -42192.9% |
| FY2022 | $0.14 | +101.9% |
| FY2021 | -$7.26 | -30.8% |
| FY2020 | -$5.55 | -967.3% |
| FY2019 | -$0.52 | - |
| FY2018 | - | - |
| FY2017 | -$0.01 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026